Group 1 - The company, Jiukang Biotechnology, announced on August 15 that it has received a patent certificate from the National Intellectual Property Administration of the People's Republic of China for a patent titled "Application of Coupling Agents in the Preparation of Detection Reagents" [2] - For the fiscal year 2024, Jiukang Biotechnology's revenue composition is entirely from the healthcare sector, accounting for 100.0% [2]